Recherche

Our role Interventional radiology is a set of techniques that are minimally invasive and use medical imaging to visualise, access and act on an organ for the purposes of diagnosis and/or treatment. Image Image Image We use ultrasound, angiography, scanners and sometimes MRI to carry out biopsies or ablations, place a stent or inject a treatment. In principle, this is possible for all the systems and most of the organs of the human body. Dr Fadi Tannouri Head of the Interhospital Department of Interventional Radiology at the H.U.B Our specialities The H.U.B’s Interhospital Department of Interventional Radiology is divided into 5 sections:   Vascular disease and embolization covers arterial or venous angiography and angioplasty (placing of a stent and prosthesis, in cooperation with  vascular surgery) and embolization. The latter consists of blocking a blood vessel for therapeutic purposes, to stop haemorrhaging for example.   The osteoarticular  section covers infiltrations, biopsies, the thermoablation of bone tumours and cementoplasty (injection of intraosseous “cement”) with or without percutaneous osteosynthesis, in cooperation with orthopaedic surgery. The nephrology, urology and gynaecology  sector covers the embolization of uterine fibroids, of benign  prostatic hypertrophy and of pelvic  varicoceles and varicose veins, as well as nephrostomy. This section also provides vascular access for dialysis and creates arteriovenous fistula by percutaneous means.  The oncological section permits the placing of implantable ports and PICC lines (venous access),  pain management through infiltration, neuroloysis or radiofrequency as well as the treatment of certain cancers (see Focus).   The thoracic pathologies section covers biopsies, haemostatic embolization, percutaneous ablation of lung tumours and thermoablation of benign thyroid nodules.    Interventional radiology also covers biopsies and drainage under ultrasound, radiological or tomodensitomety (scanner) control.     Our team Image Our specialists Focus Interventional radiology is used for a minimally invasive treatment of certain cancers and benign tumours. A number of techniques are proposed:   The destruction of liver, kidney and lung tumours by thermoablation (radiofrequencies, microwaves and cryotherapy);   Chemoembolization, radioembolization and portal embolization;    Thermoablation of benign thyroid nodules ; Embolization of prostatic arteries in the framework of benign hypertrophy of the prostate gland.    Forward-looking studies Percutaneous AVF creation outcome and complications Prostate artery embolization: comparing embolic material Varicocele embolization: comparing embolic material

Teams from the Gastroenterology and Digestive Oncology Departments of the Erasmus Hospital and Jules Bordet Institute are now working hand-in-hand within the Brussels University Hospital (H.U.B).  They propose a rapid diagnosis pathway reserved for patients showing warning signs, a positive result in a search for blood in the stools or who are at high risk.  On 22 and 23 March a giant colon will be installed in the lobbies of the Erasmus Hospital and Jules Bordet Institute. Professionals from our institutions will be there on the day to help you discover this organ and highlight the importance of screening for colorectal cancer.     Essential screening   Every year more than 8,000 Belgians, both men and women, are diagnosed with colorectal cancer. In 90% of cases they are aged over 50. One third of these persons will die from their cancer due to a late diagnosis. If detected in time, 90% of these persons are cured.  Faced with this problem, our professionals decided to put into place a rapid diagnosis pathway for patients presenting a warning sign or a high risk.  Colonoscopy screening is essential as it reduces the risk of developing colorectal cancer and reduces the mortality by 50%. This examination has therapeutic as well as diagnostic benefits as it not only allows a cancer to be detected at an early stage but also prevents its occurrence by removing colorectal polyps and early cancers.    Who is the screening targeting?   You can make an appointment with our professionals who will rapidly schedule a colonoscopy if you present warning signs such as an unexplained and lasting change in bowel movements, the presence of blood in the stools, abdominal pain or unexplained weight loss. If you have a personal or family history of polyps and/or colorectal cancer, inflammatory diseases of the digestive tube (Crohn's disease or proctocolitis) or a family history of multiple polyposis or hereditary colon cancer you will be prioritised.    With or without warning signs, from the age of 50 you can also undergo a simple test for the presence of blood in the stools, carried out in your own home following an invitation sent by the Region.    Do you show any of these symptoms? Then make an appointment with our specialists who will schedule your tests as quickly as possible on the basis of your symptoms.    Gastroenterology consultation: • Jules Bordet Institute 02 541 34 80 • Erasmus 02 555 35 04  Screening consultation at the Jules Bordet Institute (if no symptoms): 02 541 30 00   A giant colon to boost awareness   March is awareness month for colorectal cancers. On this occasion the Brussels University Hospital invites you to come and discover a giant colon. Accompanied by health professionals you can actually go inside the structure to discover this organ, in 3D, and better understand why and how to protect yourself against colorectal cancer, one of the most deadly cancers in Belgium.  The dates are 22 March at the Erasmus Hospital between 9 am and 4 pm and 23 March at the Jules Bordet Institute between 9 am and 4 pm.   

Rare diseases function Patients with a rare disease must receive proper and specific care: a rapid diagnosis followed by treatment in care units with staff trained in these rare diseases. The mission of the Rare Diseases Function (8 in Belgium) is to coordinate, with teams with the required expertise, the care pathways and scientific research and training projects of all the professionals involved  in providing an adapted and constantly evolving care.  

Did you know that 8 questions asked to your patients can already guide you in the case of a rare disease? If you can answer most of these 8 questions with 'yes' and your intuition confirms it, it would be wise to consider a rare disease. Does the patient present with acute or chronic symptoms that are inexplicable, inconsistent or non-specific, or symptoms at an unusually young age? Is there a family history? Have there been a number of periods of illness with different or identical symptoms? Is there a history of consultations with different medical specialities without satisfactory results? Are there any pathological or borderline results that are inconclusive at first sight? Has there ever been any suspicion of psychosomatic aetiology? Have there been phases of the illness going back several years? Are certain exposure scenarios known (in relation to food, leisure activities, housing, animals, travel or work)? Do not hesitate to refer your patient to a health specialist or geneticist, preferably linked to one of our designated centres of expertise for rare diseases, who are better placed to make a diagnosis.  For more information, visit https://ulbgenetics.be/fonctions-maladies-rares/ * These 8 questions were written by rare disease experts involved in the EMRaDi project.